Kodama M, Murakami K, Okimoto T, Fukuda Y, Shimoyama T, Okuda M, Kato C, Kobayashi I, Fujioka T
Influence of proton pump infibitor treatment on Helicobacter pylori stool antigen test.
World J Gastroenterol, 2012 .1.7, 18(1), 44-48

Kodama M. Murakami K., Okimoto T, Abe T, Nakagawa Y, Mizukami K. Uchida M, Inoue K, Fujioka T.
Helicobacter pylori Eradication Improves Gastric Atrophy and Intesitinal Metaplasia in Long-Term Observation. Digestion. 2012, 85(2), 126-130, Epub 2012.1.19

Shiota S, Nguyen LT, Murakami K, Kuroda A, Mizukami K. Okimoto T, Kodama M, Fujioka T, Yamaoka Y.
Association of Helicobacter pylori dupA With the Failure of Primary Eradication.
J Clin Gastroenterol , 2012.4, 46(4), 297-301

Shiota, S, Watada M, Matsunari O, Iwatani S, Suzuki R, Yamaoka Y.
Helicobacter pylori iceA, Clinical Outcomes, and Correlation with cagA: A Meta-Analysis
PLOS one, 2012.1, 7(1), 1-7

Fujioka T, Aoyama N, Sakai K, Miwa Y, Kudo M, Kawashima J, Matsubara Y, Miwa J, Yakabi K.
A large-scale nationwide multicenter prospective observational study of triple therapy using rabeprazole, amoxicillin and clarithromycin for Helicobacter pylori eradication in Japan.
J Gastroenterol, 2012.3, 47(3), 276-283, Epub 2011 Nov 9,

Kodama M, Murakami K, Okimoto T, Sato R, Uchida M. Abe T, Shiota S, Nakagawa Y, Mizukami K, Fujioka T
Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication..
J Gastroenterol , 2012.4, 47(4), 394-403, Epub 2011 Dec 6.

Matsunari O, Shiota S, Suzuki R, Watada M, Murakami K, Fujioka T, Kinjo F, Yamaoka Y
Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, southewestern island of Japan.
J Clin Microbiol, 2012.3, 50(3), 876-883, Epub 2011.12.21

Murakami K
Infection of Helicobacter species and liver disease.
J Gastroenterol, 2012 Apr 12{Epub ahead of print}

Inoue M, Gotoh K, Seike M, Masaki T, Oribe J, Honda K, Kakuma T, Yoshimatsu H.
Involvement of remnant spleen volume on the progression of steatohepatitis in diet-induced obese rats after a splenectomy. Hepatol Res 2012, 42, 203-12.

Inoue M, Gotoh K, Seike M, Masaki T, Honda K, Kakuma T, Yoshimatsu H.
Role of the spleen in the development of steatohepatitis in high-fat-diet-induced obese rats. Ewp Biol Med 2012, 237, 461-70.

Nakamura M, Nishida N, Kawashima M, Aiba Y, Tanaka A, Yasunami M, Nakamura H, Komori A, Nakamuta M, Zeniya M, Hashimoto E, Ohira H, Yamamoto K, Onji M, Kaneko S, Honda M, Yamagiwa S, Nakao K, Ichida T, Takikawa H, Seike M, Umemura T, Ueno Y, Sakisaka S, Kikuchi K, Ebinuma H, Yamashiki N, Tamura S, Sugawara Y, Mori A, Yagi S, Shirabe K, Taketomi A, Arai K, Monoe K, Ichikawa T, Taniai M, Miyake Y, Kumagi T, Abe M, Yoshizawa K, Joshita S, Shimoda S, Honda K, Takahashi H, Hirano K, Yaqura M, Kobayashi M, Muro T, Masaki N, Hirata K, Watanabe Y, Nakamura Y, Shimada M, Hirashima N, Komeda T, Sugi K, Koda M, Ario K, Takesaki E, Maehara Y, Umemoto S, Kokudo N, Tsubouchi H, Mizokami M, Nakamura Y, Tokunaga K, Ishibashi H. Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet 2012, 91, 721-8.

Abe K, Katsushima F, Kanno Y, Takahashi A, Yokokawa J, Ohira H, Arinaga T, Ide T, Nishimura J, Inoue M, Seike M, Imazeki F, Yokosuka O, Sata M.Clinical features of cirrhosis in Japanese patients with type I autoimmune hepatitis. Intern Med 2012, 51, 3323-8.

Honda K, Seike M, Maehara S, Tahara K, Anai H, Moriuchi M, Muro T.
Lamivudine treatment enabling right hepatectomy for hepatocellular carcinoma in decompensated cirrhosis. World J Gastroenterol 2012, 18, 2586-2590.

Gotoh K, Inoue M, Masaki T, Chiba S, Shiraishi K, Shimasaki T, Matsuoka K, Ando H, Fujiwara K, Fukunaga N, Aoki K, Nawata T, Katsuragi I, Kakuma T, Seike M, Yoshimatsu H. Obesity-related chronic kidney disease is associated with spleen-derived IL-10. Nephrol Dial Transplant 2013, 1120-30.

Kawaguchi T, Komori A, Seike M, Fujiyama S, Watanabe H, Tanaka M, Sakisaka S, Nakamuta M, Sasaki Y, Oketani M, Hattori T, Katsura K, Sata M.Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study. J Gastroenterol 2012, 47, 1342-51.

Gotoh K, Inoue M, Masaki T, Chiba S, Shimasaki T, Ando H, Fujiwara K, Katsuragi I, Kakuma T, Seike M, Sakata T, Yoshimatsu H. A novel anti-inflammatory role for spleen-derived interleukin-10 in obesity-induced inflammation in white adipose tissue and liver. Diabetes 2012, 61, 1994-2003.
Gotoh K, Inoue M, Masaki T, Chiba S, Shimasaki T, Ando H, Fujiwara K, Katsuragi I, Kakuma T, Seike M, Sakata T, Yoshimatsu H. A novel anti-inflammatory role for spleen-derived interleukin-10 in obesity-induced hypothalamic inflammation. J Neurochem 2012, 120, 752-64.

Oribe J, Kakuma T, Haranaka M, Okamoto K, Seike M, Yoshimatsu H. Intraperitoneal administration attenuates thiazolidinedione-induced hepatic steatosis in KKAy mice with increased hepatic peroxisome proliferator-activated receptor (PPAR)mRNA expression. Obes Res Clin Pr.2012

Mizukami K, Murakami K, Hirashita Y, Hisamatsu A, Ogawa R, Uchida M, Nakagawa Y, Okimoto T, Kodama M, Fujioka T.
Efficacy of rebamipide for low-dose aspirin-related gastrointestinal symptoms. J Clin Biochem Nutr 51: 216-220, 2012.

村上和成,　伊藤公訓,　下山克,　間部克裕
H.pylori感染症診療のこれから
日本消化器病学会雑誌,　109（1）,　60-75,　2012

兒玉雅明,　村上和成,　安部高志,　沖本忠義,　内田智久,　山岡吉生,　守山正胤,　藤岡利生
H.pyloriにおけるCagA多型性と胃粘膜傷害の免疫組織的検討
(Helicobacter pylori CagA diversity associated with the difference of gastric mucosal injury.)
日本消化器病学会雑誌,　109（1）,　37-46,　2012

兒玉雅明,　村上和成,　沖本忠義,　藤岡利生
慢性萎縮性胃炎症例におけるHelicobacter pylori除菌治療による10年間の長期経過－Prospective study－
日本ヘリコバクター学会誌,　13（2）,　43-46,　2012

村上和成
三次除菌法の現状と展望
日本ヘリコバクター学会誌,　13（2）,　29,　2012

村上和成,　沖本忠義,　藤岡利生
H.pylori除菌法の最前線
ヘリコバクター・ピロリ感染症の徹底検証,　55-65,　ライフ・サイエンス,　2012.2.25

村上和成
第19回日本消化器関連学会週間（ＪＤＤＷ）2011－臨床から－
Helicobacter Research,　16（1）,　63,　2012

兒玉雅明,　村上和成,　沖本忠義,　藤岡利生
除菌によるH.pylori関連胃炎の変化　（2）萎縮性胃炎・腸上皮化生の経年変化を巡って
臨床消化器内科,　27（3）,　293-300,　2012

村上和成
ピロリ菌除菌療法最前線
Medical ASAHI, 41(5), 18-19, 2012.5

上尾哲也、石田哲也、永松秀康、成田竜一、高橋健、小寺隆元、向井亮、米増博俊、福地聡士、清家正隆. EUS所見より術前診断し、内視鏡的に切除し得た胃Hamartomatous　inverted polypの2例.日本消化器内視鏡学会誌 54(1):24-32.2012

清家正隆.部分的脾動脈塞栓療法（PSE）」medicina.　Vol49(7)　1226-1229.2012

清家正隆　特集・生活習慣病としての肝疾患.NAFLD/NASHの合併症・予後～わが国と欧米の相違～ 医薬ジャーナル.vol 48(12).109-114.2012

清家正隆　｢肝がん・肝硬変症に対する栄養療法の新時代｣　監・編集　市田隆文・平野克治　アークメディア.　分岐鎖アミノ参による脂肪酸代謝改善作用　p10-15　2012. 東京

水上一弘、平下有香、久松朱里、小川竜、内田政広、中川善文、沖本忠義、
兒玉雅明、村上和成
低用量アスピリンによる小腸病変
INTESTINE　16: 27-32, 2012.

水上一弘、松成修、山内美佳、小川竜、中川善文、沖本忠義、兒玉雅明、村上和成
低用量アスピリンによる消化管症状と予防・治療薬の効果
消化器の臨床　15:186-191, 2012.　　

水上一弘、村上和成
低用量アスピリン起因性小腸粘膜傷害の予防
潰瘍　39: 50-53, 2012.